文献速递牙周病

牙周细菌血清抗体反应与冠心病关联的系统综述与荟萃分析

Serum antibody response against periodontal bacteria and coronary heart disease: Systematic review and meta-analysis.
PubMed 文献 · J Clin Periodontol · 2021-10-01

多数研究(61%)报告冠心病患者血清IgG抗体反应高于对照,荟萃分析显示抗Pg和抗Aa抗体升高与冠心病显著相关,合并OR分别为1.23和1.25。结论提示这些抗体或可作为检测和监测高危人群的潜在生物标志物,但免疫检测方法的不一致性需要标准化。

要点

  • 血清抗Pg和抗Aa IgG抗体升高与冠心病显著相关,合并OR分别为1.23和1.25。
  • 多数研究(61%)报告冠心病患者血清IgG抗体反应高于对照。
  • 抗体检测方法的不一致性提示需标准化免疫检测以支持生物标志物应用。

核心结论

  • 血清抗Pg和抗Aa IgG抗体反应升高与冠心病事件 modest 增加相关,可能作为检测和监测高危人群的潜在生物标志物。
  • 观察到的免疫检测设计与解释不一致,需要标准化评估牙周细菌抗体反应的免疫检测方法。

研究设计与样本

  • 多数研究(n=11)比较冠心病患者与对照的血清抗Pg和/或抗Aa IgG抗体反应。
  • 分别对血清抗Pg抗体与冠心病(n=10)及抗Aa抗体与冠心病(n=6)进行荟萃分析。

主要发现

  • 多数研究(61%)报告冠心病患者血清IgG抗体反应高于对照。
  • 荟萃分析显示抗Pg IgG抗体升高与冠心病显著相关,合并OR为1.23(95%CI:1.09-1.38,p=.001)。
  • 荟萃分析显示抗Aa IgG抗体升高与冠心病显著相关,合并OR为1.25(95%CI:1.04-1.47,p=.0004)。

关键数值与推荐

  • 抗Pg抗体与冠心病关联的合并OR为1.23(95%CI:1.09-1.38,p=.001)。
  • 抗Aa抗体与冠心病关联的合并OR为1.25(95%CI:1.04-1.47,p=.0004)。

临床怎么用

  • 血清抗Pg和抗Aa IgG抗体或可用于辅助识别和监测冠心病高危人群。
  • 临床解读抗体结果时需注意免疫检测方法的不一致性,期待标准化检测。

局限性

  • 观察到的免疫检测设计与解释不一致,影响抗体反应评估的可比性。
  • 原文未报告纳入研究的异质性、发表偏倚等具体局限性数据。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIM: The present systematic review and meta-analysis assessed the strength of a reported association between elevated serum anti-periodontal bacterial antibody responses and coronary heart disease (CHD). MATERIALS AND METHODS: Twenty original studies were identified after systematically searching five databases. The majority (n = 11) compared serum anti-Porphyromonas gingivalis (Pg) and/or anti-Aggregatibacter actinomycetemcomitans (Aa) IgG antibody responses between CHD patients and control participants. The strength of the association between serum anti-Pg antibodies and CHD (n = 10) and serum anti-Aa antibodies and CHD (n = 6) was investigated using a meta-analysis approach separately. RESULTS: Most studies (61%) reported that the serum IgG antibody responses were elevated in CHD patients than in controls. The meta-analyses showed a significant association between elevated serum IgG antibody responses (anti-Pg and anti-Aa) and CHD, with pooled odds ratios of 1.23 [95% confidence interval (CI): 1.09-1.38, p = .001] and 1.25 (95% CI: 1.04-1.47, p = .0004), respectively. CONCLUSIONS: A modest increase of CHD events in individuals with higher serum anti-Pg and anti-Aa IgG antibody responses may support their use as potential biomarkers to detect and monitor at-risk populations. However, the observed inconsistencies with the design and interpretation of immunoassays warrant standardization of the immunoassays assessing antibody responses against periodontal bacteria.

来源:J Clin Periodontol,查看原文。版权归原作者所有。

引用

  1. Joshi C, Bapat R, Anderson W, et al. Serum antibody response against periodontal bacteria and coronary heart disease: Systematic review and meta-analysis. J Clin Periodontol. 2021. PMID: 34545592. doi:10.1111/jcpe.13550

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。